Latest Actos Bladder Cancer Lawsuit Goes to Takeda

Manufacturer Triumphant in Recent Actos Personal Injury Lawsuit A lawsuit that alleged Takeda Pharmaceuticals acted negligently and failed to properly warn doctors and physicians about the dangers of their Type 2 diabetes drug Actos was decided in favor of the defendant, the medical manufacturer. In the case of An, et al v. Takeda, the jury … [Read more...]

Another Actos Bladder Cancer Lawsuit Alleges Failure to Warn

Second Actos Personal Injury Case Begins in Baltimore, Alleges Failure to Warn and Dangerous Drug Currently, Takeda Pharmaceuticals, the manufacturer of controversial Type 2 diabetes drug Actos, faces more than 3,000 personal injury and wrongful death lawsuits, linking the drug to the development of bladder cancer in those patients that ingested … [Read more...]

Takeda to Resurrect Actos as Alzheimer’s Drug

Japanese Pharmaceutical Company Aims to Develop Lower-Dose Actos into Alzheimer’s Treatment Takeda Pharmaceuticals and their partner, Zinfandel Pharma, have started a Phase III trial of Actos – generically known as pioglitazone – in people who are at risk of developing Alzheimer’s disease. The phase III trial, known as the TOMMORROW trial, will … [Read more...]

Generic Actos Study Shows No Bladder Cancer

Despite Personal Injury Lawsuits, Double-Blind Study Shows No Bladder Cancer from Generic Actos The generic form of Actos, pioglitazone, was approved for use by the FDA last August. The approval caused a huge outcry from Actos opponents, including many who are plaintiffs in personal injury lawsuits against Takeda Pharmaceuticals after taking … [Read more...]

Actos Concerns Go Global

Indian Drug Makers Fight Ban on Actos At the end of June, the government of India suspended the sale of three drugs that had been pulled from pharmacy shelves in other countries – Alagin (a painkiller), Deanxit (a depression medication), and the infamous, now-off-brand Actos. Actos was banned in France and Germany in 2011, when the countries … [Read more...]

Judge Nullifies Verdict in Actos Personal Injury Trial

Plaintiff Loses $6.5 Million Award When Judge Revokes Ruling in Actos Case On May 1st, Judge Kenneth Freeman tossed out the original verdict in the first personal injury case against Takeda Pharmaceuticals blockbuster diabetes drug, Actos. A motion filed by Takeda Pharmaceuticals convinced Judge Freeman that Actos was not the primary cause of … [Read more...]

$6.5 Million Awarded to Victim in Actos Bladder Cancer Lawsuit

Bellwether Actos Trial Returns Verdict in Favor of Plaintiff, Wins Damages The first of more than 3,000 personal injury lawsuits against Takeda Pharmaceuticals has returned a verdict, in favor of the plaintiff. On Friday, April 26th, Jack Cooper was awarded $6.5 million in personal injury damages by a jury which ruled that Takeda … [Read more...]

Takeda Concerned About Link Between Actos and Bladder Cancer, Per Filing

A New Court Filing Shows that Takeda Pharmaceuticals Knew About a Possible Link Between Actos and Bladder Cancer According to a new court filing in the multidistrict litigation (MDL) against Takeda Pharmaceuticals, the company’s executives were concerned, as early as 2003, that there might be a link between their diabetes drug Actos and an … [Read more...]

BestLawyers.comAVBetter Business Bureau